All News

That’s the objective of many healthcare providers. Brian Isetts, a pharmacy professor at the University of Minnesota and a former policy fellow at CMS, addressed the topic at the PPSI Annual Breakfast Meeting in Orlando.

GlaxoSmithKline (GSK) has begun shipping next season’s influenza vaccines to U.S. healthcare providers. GSK expects to supply 28-33 million doses for the 2014-15 flu season.

First Google. Now FedEx. The shipping giant was recently indicted by a federal jury in San Francisco for "knowingly and intentionally” conspiring to distribute substances from unauthorized pharmacies.

The Centers for Disease Control and Prevention recently launched a new webpage urging pharmacists to take a lead role in the government’s smoking cessation efforts.

CVS Caremark announced that it plans to purchase the Miami-based Navarro Discount Pharmacy chain, which includes 33 retail drug stores and a special pharmacy known as Navarro Health Services.

Members of the Joint Commission of Pharmacy Practitioners (JCPP) recently released a new resource document that details the patient care process. The document was developed over a two-year period and aims to “promote consistency in patient care service delivery across the profession.”

The Drug Enforcement Administration (DEA) ruled this week that the pain reliever tramadol is now classified as a Schedule IV controlled substance (CS).

A New York City pharmacist was recently charged with stealing 193,000 painkiller pills worth an estimated $5.6 million on the black market.

Rite Aid recently agreed to pay $498,250 to settle charges that some of its California pharmacists frequently did not provide patient consultations required by law.

As specialty pharmaceuticals consume more of the healthcare dollar, the role of managed care pharmacy will be critical.

Go ahead. Blame Obamacare. It won't make any difference.

Industry and academe collaborate on opportunities for young people to explore the range of careers in pharmacy.

Electronic prescribing of controlled substances isn't much of an improvement over previous practice.

Letters, e-mails, posts, and comments from Drug Topics readers.

New Rx, generics, OTC, and devices for pharmacists.

Two trials involving 100 totally blind individuals with circadian rhythm sleep disorders established the efficacy of the new product.

Specialty pharmacy is big and getting bigger. Some even call it a gold rush. Here are tips for those who'd like a piece of the action.

Available data indicated "serious risks associated with the use of aspirin, including increased risk of bleeding in the stomach and brain."

The Supplemental Bulletin expands upon previous guidance, focusing particularly on disease funds and legitimate copay waivers for prescribed medications.

The words might as well be tattooed on our foreheads: "I probably know the answer. I don't even charge."

A besetting problem in a screen-obsessed age, dry eye can be distractingly painful. Several companies offers products that promise relief.

Joining 12 other states and the U.S. military, Ohio will reclassify tramadol and products containing tramadol as Schedule IV controlled substances effective September 1, 2014.

Some families run to redheads. Some families witness a series of multiple births over a couple of generations. But a flock of pharmacists? Would that be nature, nurture, or morphic resonance?

Sandoz, the generic pharmaceuticals division of Novartis, has introduced an authorized generic version of Diovan (valsartan) tablets for the treatment of hypertension. The generic version of Diovan will be available in 40 mg, 80 mg, 160 mg, and 320 mg strength tablets, the same strength as the branded version.

FDA has approved another treatment for patients with peripheral T-cell lymphoma (PTCL), a rare yet aggressive type of non-Hodgkin lymphoma. Belinostat (Beleodaq) by Spectrum Pharmaceuticals was approved under FDA’s accelerated approval program. It is indicated for patients with relapsed or refractory PTCL.

During the American Society of Health-System Pharmacists’ upcoming 2014 Midyear Clinical Meeting and Exhibition in Anaheim, CA., a so-called Intelligent Pharmacy Pavilion (IPP) featuring demonstration rooms with the latest technology for hospital and ambulatory care pharmacies will be showcased.

A new survey indicates that pharmacists, nurses, and other practitioners believe IV insulin and anticoagulants should be considered the medications that can cause the most harm when used improperly.

The misuse of single-dose and multiple-dose vials has harmed thousands of patients, in some cases causing bloodborne pathogens including hepatitis B and C, meningitis, and epidural abscesses, according to the Centers for Disease Control and Prevention.